Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03102411
Other study ID # 17-006
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 9, 2017
Est. completion date September 15, 2017

Study information

Verified date May 2018
Source TriHealth Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This cross-sectional survey study is to determine the prevalence of functional gastrointestinal (GI) disorders in the general population and to describe common triggers for food-related GI symptoms.


Description:

Functional gastrointestinal disorders, involving symptoms such as gas/bloating, diarrhea, constipation and abdominal pain, are estimated to impact between 35 and 45 million Americans, an overwhelming 15-20% of the population. These symptoms are responsible for upwards of 20 billion dollars in healthcare costs and extensive loss of quality of life for sufferers. Moreover, many patients suffer in silence, with 67% of subjects waiting more than a year before treatment, and 11% waiting over 10 years. Irritable bowel syndrome is the most prevalent functional gastrointestinal disorder, and several recent studies support the idea that dietary modifications may be key to alleviating this condition.

The purpose of this study is to document gastrointestinal symptoms among the US population, as well as to ascertain awareness and utilization of dietary treatments that exist.


Recruitment information / eligibility

Status Completed
Enrollment 1881
Est. completion date September 15, 2017
Est. primary completion date September 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

Exclusion Criteria:

- Visual impairment

- Inability to read

- Inability to understand English

- Inability to use a computer to respond to questions.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Cincinnati Urogynecology Associates Cincinnati Ohio

Sponsors (1)

Lead Sponsor Collaborator
TriHealth Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Most Common Triggers for Food-related GI Symptoms (Top 5) Percentages for foods chosen as triggers ( a subject can check more than one answer - Bread, Oats, Chili, Corn, Onion, Garlic, Beans, Chocolate, Fried or greasy foods, Eggs, Soy, Red meat, Fish or shellfish, Dairy products, Nuts and seeds, Apples, Bananas, Citrus fruit, Alcohol, Coffee, Carbonated drinks, Sugar-free gum) During the past 3 months before the survey
Secondary Self-reported Functional GI Disorders Percentages of self-reported functional GI disorders ( a subject can check more than one answer - Acid reflux (GERD), Irritable bowel syndrome (IBS), Celiac disease, Inflammatory bowel disease - Crohn's or Ulcerative Colitis, Diverticulities, Gastroparesis, Leaky gut, small intestinal bacterial overgrowth (SIBO), None of the above) During the past 3 months before the survey
See also
  Status Clinical Trial Phase
Completed NCT03269617 - PHAGE Study: Bacteriophages as Novel Prebiotics N/A
Terminated NCT02974686 - Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation Phase 4
Active, not recruiting NCT05363553 - Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study N/A
Completed NCT04530929 - Analysis of the Impact of Used Probiotic Strains and Diet on Body Composition, Cardiopulmonary Efficiency and the Incidence of Gastrointestinal Disorders in Runners N/A
Withdrawn NCT03014141 - Effect of Oat Bran on Bowel Function and Appetite N/A
Completed NCT05915767 - Therapeutic Effect of Olive Leaf Tea on SIBO N/A
Recruiting NCT03011151 - Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness